Actualités Cryptologic Corp - CRY | Actions Canadian Securities Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CryoLife Sends Letter to Medafor, Inc. Shareholders

ATLANTA, Feb. 23 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Increases Stake in Medafor, Inc. to Approximately 11 Percent

ATLANTA, Feb. 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Provides Initial 2010 Financial Guidance

Company expects record revenues and operating profits in 2010 ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable...

CryoLife to Present at Upcoming Investor Conferences in New York

ATLANTA, Nov. 11 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Reports Record Quarterly Revenues of $28.2 Million

Company posts fully diluted earnings per share of $0.07 for third quarter of 2009; Revenues increased 5 percent for third quarter of 2009 compared...

CryoLife to Present at UBS Global Life Sciences Conference

ATLANTA, Sept. 14 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue...

CryoLife Announces First Clinical Use of BioFoam(R)

Newly CE Marked Product Used to Stop Bleeding During Liver Resection ATLANTA and LONDON, Sept. 10 /PRNewswire-FirstCall/ -- CryoLife, Inc...

CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material

ATLANTA, Aug. 18 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE:CRY) an implantable biological medical device and cardiovascular tissue...

CryoLife Reports Record Quarterly Revenues of $28.2 Million

Company posts fully diluted earnings per share of $0.09 for second quarter of 2009; Revenues increased 6 percent sequentially for second quarter...

CryoLife Announces First Human Implants of BioDisc(TM) Spinal Disc Repair System

ATLANTA, Sept. 6 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), a biomaterials and biosurgical device company, announced today that...

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...

Holding(s) in Company

RNS Number:8438T Country & Metropolitan PLC 05 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of...

Holding(s) in Company

RNS Number:3283T Headway PLC 16 December 2003 Headway PLC ('Headway' or the 'Company') 16 December 2003 Headway became aware on 15...

SAR - Headway plc

RNS Number:2853T Country & Metropolitan PLC 15 December 2003 FORM SAR 3 Lodge with a RIS or Newstrack if appropriate and the Takeover...

Holding(s) in Company

RNS Number:2702T Country & Metropolitan PLC 15 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cryptologic Corp (CRY)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CRY Actualités

CryoLife Sends Letter to Medafor, Inc. Shareholders

CryoLife Increases Stake in Medafor, Inc. to Approximately 11 Percent

CryoLife Provides Initial 2010 Financial Guidance

CryoLife to Present at Upcoming Investor Conferences in New York

CryoLife Reports Record Quarterly Revenues of $28.2 Million

CryoLife to Present at UBS Global Life Sciences Conference

CryoLife Announces First Clinical Use of BioFoam(R)

CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material

CryoLife Reports Record Quarterly Revenues of $28.2 Million

CryoLife Announces First Human Implants of BioDisc(TM) Spinal Disc Repair System

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Holding(s) in Company

Holding(s) in Company

SAR - Headway plc

Holding(s) in Company

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cryptologic Corp (CRY) Actualités

Cryptologic Corp (CRY)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CRY Actualités

CryoLife Sends Letter to Medafor, Inc. Shareholders

CryoLife Increases Stake in Medafor, Inc. to Approximately 11 Percent

CryoLife Provides Initial 2010 Financial Guidance

CryoLife to Present at Upcoming Investor Conferences in New York

CryoLife Reports Record Quarterly Revenues of $28.2 Million

CryoLife to Present at UBS Global Life Sciences Conference

CryoLife Announces First Clinical Use of BioFoam(R)

CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material

CryoLife Reports Record Quarterly Revenues of $28.2 Million

CryoLife Announces First Human Implants of BioDisc(TM) Spinal Disc Repair System

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Holding(s) in Company

Holding(s) in Company

SAR - Headway plc

Holding(s) in Company

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités